Skip to main content
. 2009 Jul 8;2009(3):CD007954. doi: 10.1002/14651858.CD007954
Study Reason for exclusion
Andersen 1993 Comorbidity (stroke)
Bakish 1992 Not a primary care setting
Barrett 1999 Study included secondary care patients as well as primary care patients
Barrrett 2001 Treatment in this study was undertaken by psychiatrists
Borsun 1992 Comborbidity (COPD)
Gomez 1968 Compared amitriptyline with an antipsychotic
Houston 1983 Used the Leeds depression scale
Jacobs 1965 A monoamine oxidase inhibitor
Katz 2005 All medications combined, no single drug vs placebo
Laakman 1995 Patients from psychiatrists and outpatient clinics
Lehmann 1976 Not a true RCT (a CCT)
Montgomery 1998 Patients were from psychiatrists (i.e., not in primary care setting)
O'Hara 1978 Maprotiline compared with fluphenazine/nortriptyline; placebo was also used, but delivered in combination with active treatments and not as a comparator
Paykel 1988 Primary data presented in Hollyman 1988 (see Characteristics of included studies table)
Rickels 1968 Iprindole not in current clinical use
Rickels 1971 No single antidepressant vs placebo
Rickels 1991 Not primary care setting
Schiffer 1975 No single antidepressant vs placebo
SCTG 1985 Patients were of a mixed population (both anxiety and depression)
Thompson 1994 Examined data originating from Doogan 1994 (included in this review)